Review: Therapeutic implications of hepatitis C virus resistance to antiviral drugs
Treatment of chronic hepatitis C is currently based on a combination of pegylated interferon-α and ribavirin. Neither drug exerts direct selective pressure on viral functions, meaning that interferon-α/ribavirin treatment failure is not due to selection of interferon-α- or ribavirin-resistant viral...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2009-07-01
|
| Series: | Therapeutic Advances in Gastroenterology |
| Online Access: | https://doi.org/10.1177/1756283X09336045 |